These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3167845)

  • 1. Inhibitory effect of adenosine dialdehyde on in situ murine neuroblastoma growth.
    Bostrom B; Hogenkamp HP; Mirkin BL
    Cancer Res; 1988 Nov; 48(21):5933-6. PubMed ID: 3167845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of C-1300 murine neuroblastoma cell proliferation in tissue culture and tumor growth in vivo by (Z)5'-fluoro-4',5'-didehydro-5'-deoxyadenosine (MDL 28,842), an irreversible inhibitor of S-adenosyl-L-homocysteine hydrolase.
    Zhang C; Bowlin T; Mirkin BL
    Oncol Res; 1993; 5(10-11):433-9. PubMed ID: 8054704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adenosine analogues on protein carboxylmethyltransferase, S-adenosylhomocysteine hydrolase, and ribonucleotide reductase activity in murine neuroblastoma cells.
    O'Dea RF; Mirkin BL; Hogenkamp HP; Barten DM
    Cancer Res; 1987 Jul; 47(14):3656-61. PubMed ID: 3297306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic action of adenosine nucleoside and dialdehyde analogues on murine neuroblastoma in tissue culture: structure-activity relationships.
    Mirkin BL; O'Dea RF; Hogenkamp HP
    Cancer Res; 1987 Jul; 47(14):3650-5. PubMed ID: 3594430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nerve growth factor on C-1300 murine neuroblastoma tumor growth and catecholamine content in neonatally sympathectomized mice.
    Fink DW; Mirkin BL
    J Neurosci Res; 1991 Mar; 28(3):343-51. PubMed ID: 1906944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of drug schedule on mouse neuroblastoma treated with cyclophosphamide.
    Kedar A; Wajsman Z; Moore R; Simpson LC; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):551-8. PubMed ID: 451339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the mode of administration of mitomycin on tumor and marrow response and on the therapeutic ratio.
    Rockwell S; Nierenburg M; Irvin CG
    Cancer Treat Rep; 1987 Oct; 71(10):927-34. PubMed ID: 3652056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cyclophosphamide on neuroblastoma and the bone marrow function in the experimental studies].
    Ohkawa M
    Hokkaido Igaku Zasshi; 1983 Nov; 58(6):561-74. PubMed ID: 6368346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
    J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.
    Thompson J; George EO; Poquette CA; Cheshire PJ; Richmond LB; de Graaf SS; Ma M; Stewart CF; Houghton PJ
    Clin Cancer Res; 1999 Nov; 5(11):3617-31. PubMed ID: 10589779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse.
    Fink DW; Horn PT; Mirkin BL
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1070-5. PubMed ID: 1527714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
    Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
    Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.